Clinical Trial Update: Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Latent Tuberculosis [NA]

View source ↗

Summary

A clinical trial evaluating vitamin A supplementation to modulate immune responses in latent tuberculosis infection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection

Drugs mentioned

• Vitamin A (retinol)

Snippet

Sponsor: Medical Research Council Unit, The Gambia | Conditions: Latent Tuberculosis Infection | NA | Status: WITHDRAWN